-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
المؤلفون: Lyon RP; Seagen Inc., Bothell, Washington., Jonas M; Seagen Inc., Bothell, Washington., Frantz C; Seagen Inc., Bothell, Washington., Trueblood ES; Seagen Inc., Bothell, Washington., Yumul R; Seagen Inc., Bothell, Washington., Westendorf L; Seagen Inc., Bothell, Washington., Hale CJ; Seagen Inc., Bothell, Washington., Stilwell JL; Seagen Inc., Bothell, Washington., Yeddula N; Seagen Inc., Bothell, Washington., Snead KM; Seagen Inc., Bothell, Washington., Kumar V; Seagen Inc., Bothell, Washington., Patilea-Vrana GI; Seagen Inc., Bothell, Washington., Klussman K; Seagen Inc., Bothell, Washington., Ryan MC; Seagen Inc., Bothell, Washington.
المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Dec 01; Vol. 22 (12), pp. 1444-1453.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
مواضيع طبية MeSH: Immunoconjugates*/pharmacology , Immunoconjugates*/therapeutic use , Antineoplastic Agents* , Carcinoma*, Humans ; Prognosis ; Integrins ; Cell Line, Tumor
-
9دورية أكاديمية
المؤلفون: Ramirez AB; RareCyte, Inc., Seattle, WA, USA., Bhat R; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., Sahay D; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Thangavel H; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., Hedayatpour S; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA., Dobrolecki LE; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Nardone A; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Giuliano M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Nagi C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Rimawi M; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Osborne CK; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Lewis MT; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA., Stilwell JL; RareCyte, Inc., Seattle, WA, USA., Kaldjian EP; RareCyte, Inc., Seattle, WA, USA., Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. rschiff@bcm.edu., Trivedi MV; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA. mtrivedi@central.uh.edu.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. mtrivedi@central.uh.edu.
المصدر: BMC cancer [BMC Cancer] 2019 Mar 12; Vol. 19 (1), pp. 220. Date of Electronic Publication: 2019 Mar 12.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Breast Neoplasms/*metabolism , Class I Phosphatidylinositol 3-Kinases/*genetics , Neoplastic Cells, Circulating/*metabolism , Single-Cell Analysis/*methods, Animals ; Antineoplastic Agents/pharmacology ; Biomarkers, Tumor/blood ; Breast Neoplasms/drug therapy ; Cell Line, Tumor ; Cell Separation ; Class I Phosphatidylinositol 3-Kinases/blood ; Female ; Humans ; Keratins/blood ; Leukocyte Common Antigens/blood ; Mice ; Mice, SCID ; Mutation ; Neoplasm Transplantation ; Neoplastic Cells, Circulating/drug effects ; Sequence Analysis, DNA
-
10دورية أكاديمية
المؤلفون: Ramirez AB; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., U'Ren L; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Campton DE; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Stewart D; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Nordberg JJ; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Stilwell JL; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA., Kaldjian EP; RareCyte, Inc., 312 Dexter Ave. N, Seattle, WA, 98109, USA. ekaldjian@rarecyte.com.
المصدر: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2017; Vol. 1634, pp. 163-172.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE
مواضيع طبية MeSH: Cell Separation/*methods , Cells, Immobilized/*pathology , Neoplasms/*diagnosis , Neoplastic Cells, Circulating/*pathology , Single-Cell Analysis/*methods, Cell Count ; Cell Line, Tumor ; Cell Separation/instrumentation ; Cells, Immobilized/metabolism ; Centrifugation/instrumentation ; Centrifugation/methods ; Equipment Design ; Humans ; Neoplasms/blood ; Neoplasms/pathology ; Neoplastic Cells, Circulating/metabolism ; Reagent Kits, Diagnostic/standards ; Single-Cell Analysis/instrumentation